Global Postpartum Hemorrhage Devices Market By Product Type (Uniject Prefilled Injection System, Non-Pneumatic Anti-Shock Garment, Uterine Balloon Tamponade, Condom Catheter, Foley Catheter, Rusch Balloon, Others), End Users (Hospitals, Maternity Clinics, Others), and Geography  

Purchase Option

$ 4400
$ 6600
$ 8900

The global Postpartum Hemorrhage Devices Market valued at USD 840 Mn by 2022 and is poised to grow at a significant CAGR of 4.8% from 2023-2029. Postpartum Hemorrhage (PPH) is an obstetric hemorrhagic condition that is a prime reason for maternal mortality. In postpartum hemorrhagic condition patient loss about 500mL blood in vaginal delivery or approximately 1000mL blood after cesarean delivery. It is categorized into two types namely, primary postpartum hemorrhage and secondary postpartum hemorrhage. Rising pregnancy difficulties such as multiple pregnancies, tilted uterus, and large baby size are significant factors for the Postpartum Hemorrhage Devices Market expansion. Furthermore, rising postpartum haemorrhage risk factors such as uterine atony, trauma, and anaemia cases in pregnant women, as well as technological advancements such as the devices' ability to stabilise the patient's condition until permanent treatment is provided, are propelling the PPH devices market forward. The lack of healthcare resources in poor nations, as well as the expensive cost of equipment, are projected to stifle the market for postpartum haemorrhage (PPH) devices. One of the causes of postpartum haemorrhage in pregnant women is anaemia, a major nutritional condition. According to research published by the National Center for Biotechnology Information in 2008, severe anaemia can damage the immune system, contributing to postpartum haemorrhage. PPH can be treated with first-line (non-surgical) techniques such as the use of uterotonic medicines like oxytocin and misoprostol. Second-line intervention devices, such as non-pneumatic anti-shock garments, uterine balloon tamponade, and Uniject prefilled injectable systems, are used when medications are not available. Because these devices are successful in stopping blood flow and stabilising the patient's condition until more comprehensive care is delivered.

Postpartum Hemorrhage Devices Market Summary

Study Period

2024-2030

Base Year

2023

CAGR

4.8%

Largest Market

North America

Fastest Growing Market

Europe
Postpartum Hemorrhage Devices Market Dynamics

Increase in the incidence of pregnancy complication cases like multiple pregnancies, baby size and inverted uterus, rise in risk factors like trauma, uterine atony, rise in anemia in pregnant woman, growing support from healthcare organizations, and technology advancements in the devices are anticipated to fuel the postpartum hemorrhage devices market. However, stringent regulations for postpartum hemorrhage device approval, lack of awareness about devices in underdeveloped countries, high cost of devices, and dearth of well-trained professionals may restrain the growth of postpartum hemorrhage devices market over the forecast period.

Key Features of the Reports

  • The report provides granular level information about the market size, regional market share, historic market (2018 to 2022) and forecast (2023 to 2029)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments and startup’s details that are actively working in the market
  • The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
  • The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market

Postpartum Hemorrhage Devices Market Segmentation

By Product Type
  • Uniject Prefilled Injection System
  • Non-Pneumatic Anti-Shock Garment
  • Uterine Balloon Tamponade
  • Condom Catheter
  • Foley Catheter
  • Rusch Balloon
  • Others
By End User
  • Hospitals
  • Maternity Clinics
  • Others
By Geography
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa

Frequently Asked Questions

Postpartum Hemorrhage Devices Market valued at USD 840 million by 2022 expected to reach USD 1166 million by 2029

The report covers the five regions and 15+ countries market data: North America (United States, Canada), Europe (Germany, France, Italy, Spain, and United Kingdom (UK), Asia Pacific (China, India, Japan, Australia & New Zealand), Latin America (Brazil, Mexico, Argentina) and Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa).

In our report, we provide 12-15 market players’ information into the report. However, based on the client’s request we will provide additional country and regional market players information as well.

The key opportunities for the Postpartum Hemorrhage Devices Market include the growing awareness about maternal health, increasing healthcare infrastructure in developing regions, and advancements in medical technology for effective hemorrhage management.

Europe is the fastest-growing for feed mycotoxin detoxifiers market

 

1.Executive Summary
2.Global Postpartum Hemorrhage Devices Market Introduction 
2.1.Global Postpartum Hemorrhage Devices Market  - Taxonomy
2.2.Global Postpartum Hemorrhage Devices Market  - Definitions
2.2.1.Product Type
2.2.2.End User
2.2.3.Region
3.Global Postpartum Hemorrhage Devices Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Product Landscape
3.6. New Product Launches
3.7. Impact of COVID 19 on Market
4.Global Postpartum Hemorrhage Devices Market Analysis, 2018-2022 and Forecast 2023-2029
4.1.  Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
4.2.  Year-Over-Year (Y-o-Y) Growth Analysis (%) 
4.3.  Market Opportunity Analysis 
5.Global Postpartum Hemorrhage Devices Market  By Product Type, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
5.1. Uniject Prefilled Injection System
5.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.1.3. Market Opportunity Analysis 
5.2. Non-Pneumatic Anti-Shock Garment
5.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.2.3. Market Opportunity Analysis 
5.3. Uterine Balloon Tamponade
5.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.3.3. Market Opportunity Analysis 
5.4. Condom Catheter
5.4.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
5.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.4.3. Market Opportunity Analysis 
5.5. Foley Catheter
5.5.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
5.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.5.3. Market Opportunity Analysis 
5.6. Rusch Balloon
5.6.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
5.6.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.6.3. Market Opportunity Analysis 
5.7. Others
5.7.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
5.7.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.7.3. Market Opportunity Analysis 
6.Global Postpartum Hemorrhage Devices Market  By End User, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
6.1. Hospitals
6.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.1.3. Market Opportunity Analysis 
6.2. Maternity Clinics
6.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.2.3. Market Opportunity Analysis 
6.3. Others
6.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.3.3. Market Opportunity Analysis 
7.Global Postpartum Hemorrhage Devices Market  By Region, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
7.1. North America
7.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.1.3. Market Opportunity Analysis 
7.2. Europe
7.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.2.3. Market Opportunity Analysis 
7.3. Asia Pacific (APAC)
7.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.3.3. Market Opportunity Analysis 
7.4. Middle East and Africa (MEA)
7.4.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.4.3. Market Opportunity Analysis 
7.5. Latin America
7.5.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
7.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.5.3. Market Opportunity Analysis 
8.North America Postpartum Hemorrhage Devices Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
8.1. Product Type Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
8.1.1.Uniject Prefilled Injection System
8.1.2.Non-Pneumatic Anti-Shock Garment
8.1.3.Uterine Balloon Tamponade
8.1.4.Condom Catheter
8.1.5.Foley Catheter
8.1.6.Rusch Balloon
8.1.7.Others
8.2.  End User Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
8.2.1.Hospitals
8.2.2.Maternity Clinics
8.2.3.Others
8.3.  Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
8.3.1.United States of America (USA)
8.3.2.Canada
9.Europe Postpartum Hemorrhage Devices Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
9.1. Product Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.1.1.Uniject Prefilled Injection System
9.1.2.Non-Pneumatic Anti-Shock Garment
9.1.3.Uterine Balloon Tamponade
9.1.4.Condom Catheter
9.1.5.Foley Catheter
9.1.6.Rusch Balloon
9.1.7.Others
9.2.  End User Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.2.1.Hospitals
9.2.2.Maternity Clinics
9.2.3.Others
9.3.  Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.3.1.Germany
9.3.2.France
9.3.3.Italy
9.3.4.United Kingdom (UK)
9.3.5.Spain
9.3.6.Rest of EU
9.3.7.
10.Asia Pacific (APAC) Postpartum Hemorrhage Devices Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
10.1. Product Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.1.1.Uniject Prefilled Injection System
10.1.2.Non-Pneumatic Anti-Shock Garment
10.1.3.Uterine Balloon Tamponade
10.1.4.Condom Catheter
10.1.5.Foley Catheter
10.1.6.Rusch Balloon
10.1.7.Others
10.2.  End User Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.2.1.Hospitals
10.2.2.Maternity Clinics
10.2.3.Others
10.3.  Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.3.1.China
10.3.2.India
10.3.3.Australia and New Zealand (ANZ)
10.3.4.Japan
10.3.5.Rest of APAC
11.Middle East and Africa (MEA) Postpartum Hemorrhage Devices Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
11.1. Product Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.1.1.Uniject Prefilled Injection System
11.1.2.Non-Pneumatic Anti-Shock Garment
11.1.3.Uterine Balloon Tamponade
11.1.4.Condom Catheter
11.1.5.Foley Catheter
11.1.6.Rusch Balloon
11.1.7.Others
11.2.  End User Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.2.1.Hospitals
11.2.2.Maternity Clinics
11.2.3.Others
11.3.  Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.3.1.GCC Countries
11.3.2.South Africa
11.3.3.Rest of MEA
12.Latin America Postpartum Hemorrhage Devices Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
12.1. Product Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.1.1.Uniject Prefilled Injection System
12.1.2.Non-Pneumatic Anti-Shock Garment
12.1.3.Uterine Balloon Tamponade
12.1.4.Condom Catheter
12.1.5.Foley Catheter
12.1.6.Rusch Balloon
12.1.7.Others
12.2.  End User Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.2.1.Hospitals
12.2.2.Maternity Clinics
12.2.3.Others
12.3.  Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.3.1.Brazil
12.3.2.Mexico
12.3.3.Rest of LA
13. Competition Landscape
13.1.  Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) 
13.2.1.R. Bard, Inc. (U.S.)
13.2.2.Becton, Dickinson, and Company (U.S.)
13.2.3.Cook Medical, Inc. (U.S.)
13.2.4.Utah Medical Products, Inc. (U.S.)
13.2.5.Bactiguard AB (Bactiguard Holding) (Sweden)
13.2.6.Teleflex Incorporated (U.S.)
13.2.7.3RD Stone Design, Inc. (U.S.)
13.2.8.Zoex Niasg (U.S.)
13.2.9.Revmedx Inc. (U.S.)
13.2.10.Clinical Innovations, LLC (U.S.)
13.2.11.Inpress Technologies (U.S.)
14. Research Methodology 
15. Appendix and Abbreviations 
  • R. Bard, Inc. (U.S.)
  • Becton, Dickinson, and Company (U.S.)
  • Cook Medical, Inc. (U.S.)
  • Utah Medical Products, Inc. (U.S.)
  • Bactiguard AB (Bactiguard Holding) (Sweden)
  • Teleflex Incorporated (U.S.)
  • 3RD Stone Design, Inc. (U.S.)
  • Zoex Niasg (U.S.)
  • Revmedx Inc. (U.S.)
  • Clinical Innovations, LLC (U.S.)
  • Inpress Technologies (U.S.)

Adjacent Markets